A Multi-center Randomized Double-blind Placebo-controlled Parallel-group Study to Investigate Efficacy and Safety of RO4995819 vs Placebo, as Adjunct Therapy in Patients w/Major Depressive Disorder
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 11 Sep 2013
At a glance
- Drugs Decoglurant (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 11 Sep 2013 Planned end date changed from 1 Aug 2013 to 1 May 2014 as reported by ClinicalTrials.gov.
- 11 Sep 2013 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 03 Jan 2013 New trial record